Etarfolatide

DB11810InvestigationalSmall molecule

Etarfolatide has been used in trials studying the treatment and diagnostic of Breast Neoplasms, Non Small Cell Lung Cancer, and Adenocarcinoma of the Lung.

Formula / weight: C₂₉H₃₄N₁₀O₁₁S · 730.71 g/mol (avg)
Code names: EC 20

Resolves to

Compound

UNII40UB1H6Q6TCAS479578-27-3PubChem76958396

Structure

InChIKeyYZSIZVRFVQKMJU-RDGPPVDQSA-NSMILESN[C@@H](CNC(=O)CC[C@@H](NC(=O)C1=CC=C(NCC2=CNC3=NC=NC(=O)C3=N2)C=C1)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O

Targets

P15328FOLR1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Etarfolatide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account